FDA Approves Bio-Thera Solutions' Avzivi® (bevacizumab-tnjn), a biosimilar referencing Avastin®

Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets, today announced that the United States Food and Drug Administration...

Related Keywords

United States ,China ,Li Zhang ,Zhejiang ,Guangzhou ,Guangdong ,Chinese ,Wechat Bio Thera ,Shengfeng Li ,Genentech Inc ,Biogen Inc ,Prnewswire Bio Thera Solutions Ltd ,Bio Thera Solutions Ltd ,Bio Thera Solutions ,Twitter ,Drug Administration ,Bio Thera Solution Avzivi ,Bio Thera Solution ,Thera Solutions ,United States Food ,